XL TDR® eXtreme Lateral Total Disc Replacement for the Treatment of Lumbar Degenerative Disc Dise… (NCT00927238) | Clinical Trial Compass
CompletedPhase 3
XL TDR® eXtreme Lateral Total Disc Replacement for the Treatment of Lumbar Degenerative Disc Disease (DDD)
United States246 participantsStarted 2009-07
Plain-language summary
The purpose of this study is to evaluate the safety and effectiveness of XL TDR in patients with single-level degenerative disc disease compared to other devices approved by the FDA for the same or similar indications.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18-70 years of age (inclusive and skeletally mature) at the time of surgery
* Diagnosis of image-confirmed symptomatic DDD at one of the following levels: L1/L2, L2/L3, L3/L4, or L4/L5
* DDD diagnosed using patient history and image-confirmation such as (but not limited to), MRI, CT, or CT Myelogram with one or more of the following factors: contained herniated nucleus pulposus, facet joint degeneration/changes, decreased disc height \>2mm, and/or scarring/thickening of ligamentum flavum, annulus fibrosis, or facet joint capsule
* Preoperative ODI ≥ 30 points
* Unresponsive to conservative treatment for ≥ 6 months
Exclusion Criteria:
* Symptomatic multilevel lumbar degeneration
* Chronic back or leg pain of unknown etiology
* Non-contained or extruded herniated nucleus pulpous
* Previous or other lumbar surgery at any level except prior discectomy, laminotomy, or nucleolysis at the same level
* Involved vertebral endplates dimensionally smaller than 45mm in the medial-lateral and/or 20mm in the anterior/posterior directions
* Idiopathic scoliosis
* Defect in the pars interarticularis
* Radiographic signs of significant instability at operative level
* Lytic spondylolisthesis or degenerative spondylolisthesis \> than grade 1
* Bony lumbar spinal stenosis
* Radiographic confirmation of significant facet joint disease or degeneration
* Another lumbar device implanted
* Clinically compromised vertebral bodies at the affected level due to trauma
* Presence…